Cingulate Inc. (NASDAQ:CINGW) Sees Significant Increase in Short Interest

Cingulate Inc. (NASDAQ:CINGW) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totaling 800 shares, a growth of 60.0% from the November 30th total of 500 shares. Based on an average trading volume of 45,078 shares, the days-to-cover ratio is presently 0.0 days. Based on an average trading volume of 45,078 shares, the days-to-cover ratio is presently 0.0 days.

Cingulate Stock Performance

NASDAQ CINGW traded down $0.00 on Friday, hitting $0.06. The stock had a trading volume of 161 shares, compared to its average volume of 32,148. The firm has a 50-day moving average of $0.04 and a 200-day moving average of $0.06. Cingulate has a 52-week low of $0.02 and a 52-week high of $0.18.

Cingulate Company Profile

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.